Signature Theatre - Residency Five
Skip site navigation and jump to page content

Residency Five

Signature is thrilled to introduce Residency Five, our latest and most innovative program.

Residency Five is a unique program that guarantees each playwright three world-premiere productions of new plays over the course of a five-year residency. This is the first program of its kind in the American theatre; going far beyond the traditional commissioning or workshop models, Residency Five will enable a diverse community of playwrights to build bodies of work. Residency Five playwrights receive a significant cash award, full health benefits, a stipend to attend theatre, access to Signature’s resources and staff, and like all of our playwrights, a place at the center of the artistic process.

Our Residency Five Playwrights-in-Residence:

Special thanks to The Harold and Mimi Steinberg Charitable Trust for supporting the Residency Five Program.

Additional support for Residency Five provided by Time Warner Foundation, Inc. The Residency Five Playwright Award is generously supported by the Genesis Foundation.

IMAGE: Amari Cheatom in Zooman and the Sign by Charles Fuller. Photo by Gregory Costanzo.

“We are thrilled to be underway with Residency Five. It has always been Signature’s intention to support new and mid-career playwrights as they build a body of work. Annie Baker, Will Eno, Katori Hall, Kenneth Lonergan, and Regina Taylor are the ideal first group of writers. Each is an accomplished and fascinating storyteller who has left an indelible mark on the American theatre landscape. We can’t wait to have them with us at Signature Center and welcome them into this ever growing community of writers.”
- Signature Theatre Company Founding Artistic Director James Houghton